Firas Mussa, MD, MS (he/him/his)
New York, New York
Ronald Dalman, MD
Division Chief
Stanford University
Stanford, California
Ian Loftus, MD (he/him/his)
St. George's Healthcare
London, United Kingdom
Thomas Forbes, MD (he/him/his)
Professor & Chair, Division of Vascular Surgery
University of Toronto
Toronto, Ontario, Canada
Summary: The respective journals of the SVS and ESVS publish clinical guideline recommendations on a regular schedule. Except for the recent Global Vascular CLTI Guidelines, the production and release of these guidelines are not coordinated or managed between the societies. Often recommendations differ between these societal guidelines (example: 2021 SVS vs. 2023 ESVS Carotid guidelines) or leave gaps or content areas unaddressed (2022 SVS Varicose Veins Part I vs. 2022 ESVS Chronic Venous Disease of the Lower Extremities) or unilaterally define new content areas unique to a specific society (ESVS Guidelines on Vascular Access). Particularly since many SVS members and VAM attendees do not review ESVS guideline updates on a regular basis, a Postgrad session devoted to examining differences between respective societal guidelines may provide unique insights into current patient care controversies.
Objectives:
Speaker: Ronald L. Dalman, MD – Stanford University
Speaker: Jonathan R. Boyle, MD (he/him/his)
Speaker: Peter Rossi, MD – Medical College of Wisconsin
Speaker: Thomas L. Forbes, MD (he/him/his) – University of Toronto
Speaker: Wei Zhou, MD – University of Arizona
Speaker: Ian Loftus, MD (he/him/his) – St. George's Healthcare
Speaker: Caitlin W. Hicks, MD, MS (she/her/hers) – Johns Hopkins University
Speaker: Jonathan R. Boyle, MD (he/him/his)
Speaker: Mikel Sadek, MD – New York University Langone Medical Center
Speaker: Maarit Venermo, MD, PhD (she/her/hers)